1/74
75 vocabulary flashcards covering key concepts from the lecture notes on antigen presentation, T and B cell activation, germinal centers, and checkpoint therapies.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Antigen-presenting cells (APCs)
Cells that process and present peptide antigens on MHC to T cells, initiating adaptive immune activation.
B cells, Macrophages, Dendritic Cells
Phagocytosis
Engulfment and internalization of pathogens or antigens by phagocytes.
Antigen processing
Processing of internalized antigens into peptides for MHC presentation.
MHC I
presents endogenous peptides to CD8+ T cells.
MHC II
presents exogenous peptides to CD4+ T cells.
Dendritic cells
Professional APCs that migrate to secondary lymphoid tissue to prime naive T cells; part of innate immunity.
CCR7
Chemokine receptor directing migration to lymphoid tissue in response to CCL21.
CCL21
Chemokine produced by HEV endothelium that attracts CCR7-expressing cells.
HEV (high endothelial venules)
Blood vessels in lymph nodes that allow naive T and B cells to enter from blood.
Naïve T-Cells
T cells that have not yet encountered their antigen; circulate through lymphoid tissues.
originate in bone marrow
L-selectin
Adhesion molecule (CD62L) mediating tethering to endothelium via CD34 and GlyCAM-1.
CD34
Endothelial ligand for L-selectin, facilitating lymphocyte homing to lymph nodes.
GlyCAM-1
Endothelial ligand for L-selectin during entry into lymph nodes.
LFA-1
Integrin on T cells that strengthens adhesion to ICAM-1/2, aiding diapedesis.
ICAM-1/ICAM-2
Adhesion molecules that bind LFA-1 to enable firm adhesion and migration.
TCR
recognizes peptide-MHC complexes.
CD4
Co-receptor on helper T cells recognizing MHC II.
MHC II–CD4 signaling
Engagement initiates T-cell activation and transcriptional changes.
Co-stimulation
Second signal essential for full T-cell activation, usually CD28–B7 interaction.
B7-1 (CD80)
Co-stimulatory molecule on APCs engaging CD28 on T cells.
B7-2 (CD86)
Co-stimulatory molecule on APCs engaging CD28 on T cells.
CD28
T-cell receptor delivering the co-stimulatory signal by binding B7.
Anergy
T-cell functional inactivation due to lack of co-stimulation.
CD3
Component of the TCR complex that transduces activation signals.
Protein Kinase C (PKC)
Kinase involved in signal transduction during T-cell activation.
Tyrosine Kinases
Enzymes that phosphorylate signaling proteins to propagate T-cell signals.
IL-2
Autocrine growth factor promoting T-cell proliferation; supports regulatory T cells.
CD25
IL-2 receptor alpha chain; marker of activated T cells with high-affinity IL-2 receptor.
Regulatory T-cells (Tregs)
T cell subset that suppresses immune responses to maintain tolerance.
CD40L
CD40 ligand on activated helper T cells that engages CD40 on B cells and APCs.
CD40
Receptor on B cells and APCs that triggers activation upon CD40L binding.
Th1
T helper subset promoting cell-mediated immunity; IFN-γ production and macrophage activation.
Th2
T helper subset promoting humoral immunity; IL-4, IL-5, IL-13; IgE production.
Th17
T helper subset driving inflammation; IL-17 and IL-22; neutrophil recruitment.
TFH (T follicular helper cells)
T helper cells that assist B cells in germinal centers via CD40L and cytokines.
IL-12
Cytokine that promotes Th1 differentiation.
IFN-γ
activates macrophages and promotes IgG isotype switching.
IL-4
Cytokine promoting Th2 differentiation; enhances IgE class switching.
IL-5
Cytokine supporting eosinophil growth and B cell activity; linked to IgE production.
IL-13
Cytokine promoting allergic responses and IgE production.
IL-1
Pro-inflammatory cytokine promoting Th17 differentiation with IL-6.
IL-6
Pro-inflammatory cytokine aiding Th17 differentiation; promotes acute phase responses.
IL-15
Cytokine supporting memory T-cell survival and expansion.
Memory T-cells
Long-lived T cells that respond rapidly upon re-exposure to antigen.
CD40–CD40L interaction
Binding between B cells and helper T cells essential for B-cell activation and isotype switching.
B-cell activation
Process by which B cells recognize antigen and receive signals to proliferate and differentiate.
BCR (B-cell receptor)
Surface immunoglobulin that binds specific antigen to initiate signaling.
TLR (Toll-like receptor)
Pattern-recognition receptor providing innate signals to B cells and other cells.
Complement receptor
B-cell receptor for complement components aiding activation.
B7 expression
Upregulation of B7 on APCs enabling efficient T-cell co-stimulation.
Extrafollicular B-cell proliferation
Early B-cell expansion outside germinal centers after activation.
Isotype switching
Class switch of antibody heavy chain to IgG, IgA, or IgE from IgM/IgD.
Somatic hypermutation
Mutation in variable regions of immunoglobulin genes increasing affinity.
Germinal centers
Lymph node structures where B cells undergo maturation and selection.
Dark zone
GC region with rapidly dividing B cells undergoing hypermutation.
Light zone
GC region where higher-affinity B cells are selected with TFH help.
Memory B-cells
Long-lived B cells that persist for rapid response on re-exposure.
Plasma cells
Antibody-secreting B cells, often long-lived in bone marrow.
TFH help in B activation
TFH cells provide signals to B cells for germinal center maturation.
Antigen processing by B-cells
B cells internalize antigen and present peptides on MHC II to CD4+ T cells.
CD40–CD40L in B-cell differentiation
Interaction promotes B-cell maturation and class switching.
Cytokines directing isotype switching
IFN-γ promotes IgG; IL-4/IL-5/IL-13 promote IgE class switching.
IgM
First antibody isotype produced in the initial immune response.
IgD
B-cell receptor isotype co-expressed with IgM on naive B cells.
IgG
High-affinity, class-switched antibody predominant in systemic immunity.
Th1 vs Th2 outcomes
Th1 drives cell-mediated immunity and IgG; Th2 drives humoral responses and IgE.
Th1: Macrophage activation (M1)
IFN-γ from Th1 activates macrophages toward the M1 phenotype.
Th2: Eosinophils and IgE
Th2 cytokines promote eosinophil/mast cell responses and IgE production.
Th17: IL-17 and IL-22
Cytokines recruit neutrophils and monocytes; strengthen barrier defense.
IFN-γ and IgG switching
IFN-γ promotes IgG class switching in B cells.
PD-1
Programmed death-1 receptor on T cells that dampens activation when engaged.
PD-L1
Ligand on tumor and other cells that binds PD-1 to inhibit T-cell responses.
Pembrolizumab
Anti-PD-1 antibody blocking PD-1–PD-L1/PD-L2 interaction to sustain T-cell activity.
Nivolumab
Anti-PD-1 antibody used in cancer immunotherapy to enhance T-cell responses.
CTLA-4
Inhibitory receptor that downregulates T-cell responses; blockade enhances immunity.